The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of outcomes with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 versus real-world standard of care (RW SOC) for patients (pts) with triple-class exposed relapsed/refractory multiple myeloma (RRMM).
 
Thomas G. Martin
Consulting or Advisory Role - GlaxoSmithKline; Juno Therapeutics
Research Funding - AMGEN (Inst); Janssen Oncology; Janssen Oncology; Sanofi (Inst)
 
Amrita Y. Krishnan
Leadership - Sutro Biopharma
Stock and Other Ownership Interests - BMS
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; GlaxoSmithKline; Janssen Oncology; Pfizer; Regeneron
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Janssen Oncology (Inst)
 
Kwee Yong
Honoraria - Amgen; Janssen-Cilag; Roche/Genentech; Sanofi; Takeda
Consulting or Advisory Role - Janssen-Cilag
Speakers' Bureau - Sanofi; Takeda; Takeda
Research Funding - Amgen; Autolus; Janssen-Cilag; Sanofi; Takeda (Inst)
Travel, Accommodations, Expenses - Takeda
 
Katja Weisel
Honoraria - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Oncopeptides; Roche/Genentech; Sanofi; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Sanofi; Takeda
Research Funding - Amgen (Inst); Celgene (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
 
Maneesha Mehra
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Sandhya Nair
Employment - Johnson & Johnson
 
Keqin Qi
Employment - Janssen
Stock and Other Ownership Interests - Bristol-Myers Squibb; Johnson & Johnson
 
Anil Londhe
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Joris Diels
Employment - Janssen
 
Concetta Crivera
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Carolyn Chang Jackson
Employment - Janssen Research & Development
Consulting or Advisory Role - Memorial Sloan-Kettering Cancer Center
 
Yunsi Olyslager
No Relationships to Disclose
 
Martin Vogel
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Jordan Mark Schecter
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen
 
Arnob Banerjee
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Satish Valluri
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Sanofi; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics
 
Jesus G. Berdeja
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); Secura Bio (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celularity (Inst); Constellation Pharmaceuticals (Inst); crispr therapeutics (Inst); CURIS (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Glenmark (Inst); Ichnos Sciences (Inst); Janssen (Inst); Kesios Therapuetics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst); Vivolux (Inst)
 
Sundar Jagannath
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Legend Biotech; Sanofi; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Legend Biotech